Benzinga | Aug 3, 2020 06:55AM EDT

Lannett Announces Launch Of FDA Approved Levothyroxine Tablets

PHILADELPHIA, Aug. 3, 2020 /PRNewswire/ --Lannett Company, Inc. (NYSE:LCI) today announced the launch of Cediprof, Inc.'s FDA approved Levothyroxine Sodium Tablets USP, under the companies recently announced interim exclusive supply and distribution agreement.